Medexus Pharmaceuticals, Inc. (MDP.TO)
3.10
-0.06
(-1.90%)
CAD |
TSX |
Mar 06, 16:00
Medexus Pharmaceuticals Cash from Investing (TTM) : -15.98M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| NexgenRx, Inc. | -0.8103M |
| Zentek Ltd. | 1.750M |
| Aurora Spine Corp. | -0.5967M |
| Cronos Group, Inc. | -106.98M |
| NeuPath Health, Inc. | -0.871M |